36 results
424B3
Arcturus Therapeutics Holdings, Inc.
12 Apr 19
Prospectus supplement
4:39pm
; Voting Rights; Votes Required for Approval” starting on page 94 of the accompanying proxy statement/prospectus.
If you have any questions about … SHAREHOLDERS AND DELAWARE STOCKHOLDERS
THE SPECIAL MEETING
General
Time, Place and Date
Purpose of the Special Meeting
Record Date; Voting Rights; Votes Required
S-4/A
Arcturus Therapeutics Holdings, Inc.
11 Apr 19
Registration of securities issued in business combination transactions (amended)
5:26pm
eligibility to vote at, and voting procedures for, the Special Meeting, please refer to “The Special Meeting—Record Date; Voting Rights; Votes Required …
THE SPECIAL MEETING
General
Time, Place and Date
Purpose of the Special Meeting
Record Date; Voting Rights; Votes Required for Approval
Proxies
How You
S-4
ARCT
Arcturus Therapeutics Holdings Inc
15 Mar 19
Registration of securities issued in business combination transactions
9:35pm
; Voting Rights; Votes Required for Approval” starting on page 94 of the accompanying proxy statement/prospectus.
If you have any questions about … AND DELAWARE STOCKHOLDERS
THE SPECIAL MEETING
General
Time, Place and Date
Purpose of the Special Meeting
Record Date; Voting Rights; Votes Required
S-3
gqiup qyuplmr
21 Jun 19
Shelf registration
5:29pm
S-3ASR
3z0j1ob wllqgp
7 Dec 20
Automatic shelf registration
4:15pm
424B5
g8p y0bkc7r24pe
5 Aug 19
Prospectus supplement for primary offering
9:08am
424B5
r9chpu76jo9ww3daqw
2 Aug 19
Prospectus supplement for primary offering
4:28pm
424B5
3lnnfz
27 Mar 20
Prospectus supplement for primary offering
5:19pm
424B5
jv1ys
27 Sep 19
Prospectus supplement for primary offering
4:14pm
PRE 14A
tudpo3
2 Oct 20
Preliminary proxy
4:20pm
424B5
g4jvuiqxyq7d9xf2l
17 Apr 20
Prospectus supplement for primary offering
4:02pm
424B5
0s5mz6kx
15 Apr 20
Prospectus supplement for primary offering
4:14pm
8-K
EX-10.1
b90hcgm1quh
20 Jun 19
License Agreement to Develop Additional Nucleic Acid Therapies for Rare Diseases
6:06am
424B5
rob3 ns446u39o3bd1
30 Jul 20
Prospectus supplement for primary offering
6:01am